Proteomic analysis of experimentally induced azole resistance in Candida glabrata

Journal of Antimicrobial Chemotherapy

Volumn 58, Issue 2, 2006, Pages 434-438

  Rogers, P David ^a,b,c   Vermitsky, John Paul ^d   Edlind, Thomas D ^d   Hilliard, George M ^b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^c LE BONHEUR CHILDREN'S MEDICAL CENTER   (United States)

^d DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Antifungals; Efflux pumps; Lanosterol demethylase

Indexed keywords

ABC TRANSPORTER; CADMIUM; ERGOSTEROL; FLUCONAZOLE; GLYCEROL; MEMBRANE PROTEIN; POLYACRYLAMIDE; PYRROLE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BIOSYNTHESIS; CANDIDA GLABRATA; CONTROLLED STUDY; DNA FINGERPRINTING; ENVIRONMENTAL EXPOSURE; FUNGAL STRAIN; GENETIC TRANSCRIPTION; GLYCOLYSIS; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN ISOLATION; PROTEIN METABOLISM; PROTEOMICS; TRANSCRIPTION REGULATION; TWO DIMENSIONAL GEL ELECTROPHORESIS; UPREGULATION;

ANTIFUNGAL AGENTS; AZOLES; CANDIDA GLABRATA; DRUG RESISTANCE, FUNGAL; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FUNGAL PROTEINS; GENE EXPRESSION REGULATION, FUNGAL; MUTATION; PROTEOME; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 33748061642     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkl221     Document Type: Article

References (10)

1. Bodey GP, Mardani M, Hanna HA et al. The epidemiology of Candida glabrata and Candida albicans fungemia in immunocompromised patients with cancer. Am J Med 2002; 112: 380-5.
2. Ghannoum MA, Rice LB. Antifungal agents: Mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance. Clin Microbiol Rev 1999; 12: 501-7.
3. Bennett JE, Izumikawa K, Marr KA. Mechanism of increased fluconazole resistance in Candida glabrata during prophylaxis. Antimicrob Agents Chemother 2004; 48: 1773-7.
4. Redding SW, Kirkpatrick WR, Saville S et al. Multiple patterns of resistance to fluconazole in Candida glabrata isolates from a patient with oropharyngeal candidiasis receiving head and neck radiation. J Clin Microbiol 2003; 41: 619-22.
5. Vermitsky JP, Earhart KE, Smith L et al. PDR1 regulates multidrug resistance in Candida glabrata: Gene disruption and genome-wide expression studies. Mol Microbiol 2006; in press.
6. Marichal P, Vanden Bossche H, Odds FC et al. Molecular biological characterization of an azole-resistant Candida glabrata isolate. Antimicrob Agents Chemother 1997; 41: 2229-37.
7. Niimi M, Nagai Y, Niimi K et al. Identification of two proteins induced by exposure of the pathogenic fungus Candida glabrata to fluconazole. J Chromatogr B Analyt Technol Biomed Life Sci 2002; 782: 245-52.
8. Vido K, Spector D, Lagniel G et al. A proteome analysis of the cadmium response in Saccharomyces cerevisiae. J Biol Chem 2001; 276: 8469-74.
9. Kobayashi D, Kondo K, Uehara N et al. Endogenous reactive oxygen species is an important mediator of miconazole antifungal effect. Antimicrob Agents Chemother 2002; 46: 3113-7.
10. Kan VL, Geber A, Bennett JE. Enhanced oxidative killing of azole-resistant Candida glabrata strains with ERG11 deletion. Antimicrob Agents Chemother 1996; 40: 1717-9.